共 22 条
- [11] The IL-17 neutralizing antibody treatment reverses the inflammatory response mediated by Th17 cells and alveolar enlargement in an experimental model of chronic obstructive pulmonary disease (COPD)EUROPEAN RESPIRATORY JOURNAL, 2024, 64Moreira, Alyne RianiMattos, LeticiaUchoa, CamilaBerti, Veronica CamargoAlmeida, FrancineIto-Uchoa, JulianaSilva, AlexLima, FrancieleSilva, CintiaBezerra, SuellenTiberio, Iolandados Santos Lopes, Fernanda Degobbi Tenorio Quirino
- [12] Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-cells Are UnaffectedFRONTIERS IN IMMUNOLOGY, 2018, 9Brinkhoff, AlexandraSieberichs, AnnetteEngler, HaraldDolff, SebastianBenson, SvenKorth, JohannesSchedlowski, ManfredKribben, AndreasWitzke, OliverWilde, Benjamin
- [13] Anti-IL-23 receptor monoclonal antibody prevents CD4+ T cell-mediated colitis in association with decreased systemic Th1 and Th17 responsesEUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 824 : 163 - 169Imamura, EmikoTaguchi, KatsunariSasaki-Iwaoka, HarunaKubo, SatoshiFurukawa, ShigetadaMorokata, Tatsuaki
- [14] Interferon (IFN) beta-1a induces IL-27 and IL-12, and down-regulates IL-23 and IL-1beta in dendritic cells (DCs), establishing inhibitory conditions for Th-17 cell differentiation: Implications for treatment of multiple sclerosis (MS)FASEB JOURNAL, 2008, 22Ramgolam, VinodSpeer, DanielleMarkovic-Plese, Silva
- [15] A truncated IL-12rβ1 receptor ameliorates chronic graft-versus-host disease-induced lupus nephritis by inhibiting Th1 and Th17 cellsINTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 544 - 551Wang, ChenGuo, WeiCai, DiWang, XinYu, DongmeiGao, XiangdongYao, Wenbing
- [16] Anti-CD3 antibody ameliorates experimental autoimmune uveitis (EAU) by increase in IL-10 and TGF-1-secreting regulatory T cells and down-regulation of both Th1 and Th17 T cellsJOURNAL OF IMMUNOLOGY, 2009, 182Ke, YanJiang, GuominBian, YangWang, YaliKaplan, Henry J.Shao, Hui
- [17] IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- micePLOS ONE, 2018, 13 (03):Constanza Mayordomo, AndreaEduardo Silva, JuanVirginia Gorlino, CarolinaLuis Arias, JoseBeron, WalterSilvia Di Genaro, Maria
- [18] Increased Prevalence of Circulating Novel IL-17 Secreting Foxp3 Expressing CD4+T Cells and Defective Suppressive Function of Circulating Foxp3+Regulatory Cells Support Plasticity Between Th17 and Regulatory T Cells in Inflammatory Bowel Disease PatientsINFLAMMATORY BOWEL DISEASES, 2013, 19 (12) : 2522 - 2534Ueno, AitoJijon, HumbertoChan, RonaldFord, KimHirota, ChristinaKaplan, Gilaad G.Beck, Paul L.Iacucci, MariettaGasia, Miriam FortBarkema, Herman W.Panaccione, RemoGhosh, Subrata
- [19] Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate)Current Gastroenterology Reports, 2021, 23 (12)Sattler L.Hanauer S.B.Malter L.
- [20] Crohn's disease patients with Ustekinumab-induced remission are characterized by high baseline p35 cytokines subunits in LPMC and high IL-23 receptor expression in the lamina propria Th1 cellsJOURNAL OF CROHNS & COLITIS, 2024, 18 : I937 - I939Onali, S.Di Petrillo, A.Raho, N.Favale, A.Carpineti, C.Cadoni, M.Loddo, E.Fantini, M. C.